Products for Research Use Only
RegisterLogin

3-Deazaadenosine

CAT: 0804-HY-W013332-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W013332-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 μM; 3-Deazaadenosine has anti-inflammatory, anti-proliferative and anti-HIV activity.
CAS Number
6736-58-9
UNSPSC
12352005
Hazard Statement
H302, H312, H315, H319, H331, H335
Target
HIV; S-adenosylhomocysteine hydrolase (SAHH)
Type
Reference compound
Related Pathways
Anti-infection; Epigenetics; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/3-Deazaadenosine.html
Purity
99.87
Solubility
DMSO : 130 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C3=C(C(N)=NC=C3)N=C2
Molecular Formula
C11H14N4O4
Molecular Weight
266.26
Precautions
H302, H312, H315, H319, H331, H335
References & Citations
[1]Gordon RK, et al. Anti-HIV-1 activity of 3-deaza-adenosine analogs. Inhibition of S-adenosylhomocysteine hydrolase and nucleotide congeners. Eur J Biochem. 2003 Sep;270 (17) :3507-17.|[2]Jeong SY, et al. 3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual effects on NF-kappaB regulation. Inhibition of NF-kappaB transcriptional activity and promotion of IkappaBalpha degradation. J Biol Chem. 1999 Jul 2;274 (27) :18981-8.|[3]Sedding DG, et al. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res. 2009 May 22;104 (10) :1192-200.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Citation 01
Am J Physiol Cell Physiol. 2024 Mar 1;326 (3) :C684-C697.|Arch Toxicol. 2021 Jan;95 (1) :299-309.|Biomolecules. 2025 Aug 18;15 (8) :1188.|BMC Biol. 2024 May 3;22 (1) :104.|Cancer Cell Int. 2023 Dec 18;23 (1) :330.|Cancer Res. 2021 Sep 15;81 (18) :4778-4793.|Cell Biol Int. 2025 Jun;49 (6) :674-691.|Cell Death Dis. 2025 Oct 27;16 (1) :767.|Cell Mol Biol Lett. 2024 Jul 3;29 (1) :97.|Cell Rep. 2021 Jan 5;34 (1) :108580.|Cell Signal. 2025 Jan 22:111623.|Environ Pollut. 2023 Aug 15;331 (Pt 2) :121798.|Eur J Pharmacol. 2024 Dec 31:177247.|Exp Cell Res. 2024 Aug 27:114226.|Exp Cell Res. 2025 Mar 25:114538.|Genomics. 2022 Jul;114 (4) :110424.|Inflammation. 2025 Nov 7.|Int J Biol Sci. 2023 Jan 1;19 (2) :593-609.|J Cancer. 2023 Apr 17;14 (7) :1117-1131.|J Neurosci. 2023 Mar 1;43 (9) :1456-1474.|Oncogene. 2024 Apr;43 (17) :1288-1302.|Research Square Print. 2022 May.|Transpl Immunol. 2024 Jul 10:102083.|bioRxiv. 2024 May 18.|J Clin Invest. 2025 July 22.|Water Biol Secur. 2025 Apr 18.

Related Products

CatalogName
HY-1031591-Deazaadenosine
HY-W048480-017-Iodo-2',3'-dideoxy-7-deazaadenosine
HY-1342457-Deazaadenosine 5'-phosphate
HY-W081226-013,3,3-Trifluoropropionyl chloride
HY-W127810-013,3',3''-Nitrilotripropionic Acid
HY-W4403031,1',3,3,3',3'-Hexamethylindotricarbocyanine (perchlorate)
HY-D1075-011,1',3,3,3',3'-Hexamethylindodicarbocyanine (iodide)
HY-W1146693- (3- (3-Ethoxy-3-oxopropoxy) propoxy) propanoicacid
HY-79034-013,3-Dimethylcyclohexanone
HY-131942SFTX-3.3

Alternative Products

CatalogName
sc-2164283-Deazaadenosine
S0787-25mg3-Deazaadenosine hydrochloride

Popular Products